AI and Autonomy Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform The acquisition targets a cancer monitoring market that the companies estimate could reach USD$20 billion Joseph Morton4 days ago
Medical and Pharmaceutical Agilon Health soars after surpassing Q1 expectations Stock rose by more than 115% after multiple financial metrics improved Rowan DunneMay 7, 2026
Cannabis Trump signs long-awaited executive order to reschedule cannabis Stocks dropped as many investors were left largely disappointed Rowan DunneDecember 19, 2025
Health & Wellness The Canadian healthcare system leaves cancer patients with considerable out of pocket expenses The data also noted that 23 per cent of Canadians diagnosed with cancer Joseph MortonFebruary 6, 2025